Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

A novel PAR2 agonist induces gastric mucosal cytoprotection

March 3, 2005

AstraZeneca imparts the synthesis of three series of H+/K+-ATPase inhibitors

March 2, 2005

Advitech and the CHULRC to test XP-828L for inflammatory bowel diseases

March 1, 2005

Pegasys receives FDA approval for HIV-HCV coinfected patients

Feb. 28, 2005

Promising results reported for the purgative INKP-102 in colonoscopy patients

Feb. 28, 2005

Pegasys approved for hepatitis B in Europe

Feb. 25, 2005

Tripep reports on ChronVac developments

Feb. 25, 2005

Entecavir reported effective against recurrent HBV viremia in HIV/HBV coinfection

Feb. 24, 2005

Novel anti-HCV agents claimed by the Italian researchers

Feb. 22, 2005

Novel anti-hepatitis C virus agents developed by Anadys researchers

Feb. 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...